How Much Did Neuralink Raise? Headquarters, Funding & Key Investors

Neuralink has raised $1.29 billion in total funding across multiple rounds, including Series E ($650M, May 2025), Series D ($323M + $43M, 2023), and Series C ($205M, 2021). Backed by top investors such as Founders Fund, Google Ventures, Sequoia Capital, and ARK Investment Management, the company reached a $5 billion valuation as of June 2023. Founded in 2016, Neuralink continues to attract capital to advance its implantable brain-computer interfaces, accelerating its mission to revolutionize human–machine interaction and restore lost neurological functions.

How Much Did Neuralink Raise? Funding & Key Investors

Neuralink is a leading neurotechnology company pioneering the integration of the human brain with artificial intelligence. The company’s mission is to enhance human potential by enabling direct communication between the brain and digital systems. Through its implantable devices the N1 Implant and Blindsight Neuralink aims to revolutionize medical treatments for neurological disorders, paralysis, and blindness.

What Is Neuralink and What Does It Do?

Neuralink, founded in 2016 by Elon Musk, Jared Birchall, and Urs D. Baumann, is a San Francisco-based (United States) company specializing in neurology and brain-computer interfaces.

With a team of approximately 331 employees, Neuralink designs and manufactures implantable devices that connect the human brain to digital systems. Its flagship product, the N1 Implant (The Link), enables users to control computers and mobile devices with their thoughts.

Neuralink’s work bridges neuroscience and AI, pushing the limits of human-machine symbiosis.

How Much Funding Has Neuralink Raised?

*Seed Round* • Amount Raised: $1.62 M
• Date: October 2010
• Motivation: To fund foundational neuroscience research and early brain–machine interface prototypes.
*Series B* • Amount Raised: $27 M
• Date: August 2017
• Motivation: To scale R&D and initiate device miniaturization studies.
*Series C (Round 1)* • Amount Raised: $39.3 M
• Date: April 2019
• Motivation: To advance device safety trials and expand engineering teams.
*Series C (Round 2)* • Amount Raised: $205 M
• Date: July 2021
• Lead Investors: Vy Capital, Google Ventures, DFJ Growth, Valor Equity Partners, Craft Ventures, Gigafund, Founders Fund
• Motivation: To refine the N1 Implant and prepare for early-stage human clinical trials.
*Series D (Round 1)* • Amount Raised: $323 M
• Date: August 2023
• Lead Investors: Founders Fund
• Motivation: To expand production and accelerate vision restoration research.
*Series D (Round 2)* • Amount Raised: $43 M
• Date: November 2023
• Lead Investors: Founders Fund
• Motivation: To continue human trials and strengthen neural data processing capabilities.
*Series E* • Amount Raised: $650 M
• Date: May 2025
• Lead Investors: Founders Fund, Google Ventures, Sequoia Capital, Lightspeed Venture Partners, Thrive Capital
• Motivation: To commercialize brain–computer interface devices and scale vision restoration programs.

Total Funding Raised: $1.29 Billion

Current Valuation: $5 Billion (as of June 2023)

Latest Funding Date: May 2025

Key Investors

*Founders Fund* • Details: Venture capital firm founded by Peter Thiel, known for backing breakthrough technologies and frontier science companies.
• Investment Focus Areas: Aerospace, biotechnology, deep tech, and AI.
• Notable Investments: SpaceX, Palantir, Stripe.
*Google Ventures (GV)* • Details: Investment arm of Alphabet Inc., supporting technology innovation across industries.
• Investment Focus Areas: AI, life sciences, and next-generation computing.
• Notable Investments: Slack, Uber, Nest.
*Sequoia Capital* • Details: Global venture capital firm investing in technology-driven, high-impact startups.
• Investment Focus Areas: AI, healthcare, enterprise software.
• Notable Investments: Apple, Zoom, DoorDash.
*Lightspeed Venture Partners* • Details: Venture capital firm backing early and growth-stage technology ventures worldwide.
• Investment Focus Areas: AI, SaaS, and deep tech.
• Notable Investments: Snap, Affirm, Rubrik.
*ARK Investment Management* • Details: Investment firm led by Cathie Wood, focused on disruptive innovation.
• Investment Focus Areas: AI, robotics, neuroscience, and biotechnology.
• Notable Investments: Tesla, CRISPR Therapeutics, Coinbase.

Where Is Neuralink’s Headquarters?

Neuralink is headquartered in San Francisco, California, a hub for biotech, neuroscience, and AI innovation. Its location allows close proximity to Silicon Valley’s deep-tech investors, elite research institutions, and a skilled talent pool across neuroengineering, robotics, and AI. The strategic location strengthens Neuralink’s ability to collaborate with global technology and medical leaders.

What’s Next for Neuralink?

Neuralink’s next phase centers on clinical validation and commercialization. The company plans to expand human trials for the N1 Implant, refine its Blindsight vision-restoration device, and seek FDA approvals for broader medical use. With over $1.29 billion in funding and firm investor backing, Neuralink aims to pioneer brain-controlled computing, bridging the gap between neuroscience and AI to treat neurological conditions and enhance human cognitive capabilities.

Get Investor & Funding Insights with TexAu

TexAu helps sales and business teams uncover detailed fundraising information on companies like Neuralink. Use the platform to research investors, track funding rounds, and gather actionable insights to strengthen prospecting and business strategy.